Coverage
-
August 07, 2013
A Texas federal judge ruled Tuesday that Accuhale LLC's suit alleging AstraZeneca LP infringed a patent for a pressurized metered-dose inhaler indicator could move forward, saying AstraZeneca hadn't proven that the patent was indefinite and invalid.
1 other articles on this case.
View all »